Daniel Steven L, Moradi Luke, Paiste Henry, Wood Kyle D, Assimos Dean G, Holmes Ross P, Nazzal Lama, Hatch Marguerite, Knight John
Department of Biological Sciences, Eastern Illinois Universitygrid.255392.a, Charleston, Illinois, USA.
School of Medicine, University of Alabama at Birminghamgrid.265892.2, Birmingham, Alabama, USA.
Appl Environ Microbiol. 2021 Aug 26;87(18):e0054421. doi: 10.1128/AEM.00544-21.
Oxalobacter formigenes, a unique anaerobic bacterium that relies solely on oxalate for growth, is a key oxalate-degrading bacterium in the mammalian intestinal tract. Degradation of oxalate in the gut by plays a critical role in preventing renal toxicity in animals that feed on oxalate-rich plants. The role of in reducing the risk of calcium oxalate kidney stone disease and oxalate nephropathy in humans is less clear, in part due to difficulties in culturing this organism and the lack of studies which have utilized diets in which the oxalate content is controlled. Herein, we review the literature on the 40th anniversary of the discovery of , with a focus on its biology, its role in gut oxalate metabolism and calcium oxalate kidney stone disease, and potential areas of future research. Results from ongoing clinical trials utilizing in healthy volunteers and in patients with primary hyperoxaluria type 1 (PH1), a rare but severe form of calcium oxalate kidney stone disease, are also discussed. Information has been consolidated on strains and best practices to culture this bacterium, which should serve as a good resource for researchers.
产甲酸草酸杆菌是一种独特的厌氧菌,仅依靠草酸盐生长,是哺乳动物肠道中关键的草酸盐降解细菌。肠道中草酸盐的降解对于以富含草酸盐的植物为食的动物预防肾脏毒性起着关键作用。产甲酸草酸杆菌在降低人类草酸钙肾结石病和草酸肾病风险方面的作用尚不清楚,部分原因是培养这种微生物存在困难,且缺乏利用控制草酸盐含量饮食的研究。在此,我们在产甲酸草酸杆菌发现40周年之际回顾相关文献,重点关注其生物学特性、在肠道草酸盐代谢和草酸钙肾结石病中的作用以及未来潜在的研究领域。还讨论了正在进行的在健康志愿者和1型原发性高草酸尿症(PH1)患者(一种罕见但严重的草酸钙肾结石病形式)中使用产甲酸草酸杆菌的临床试验结果。已汇总了有关产甲酸草酸杆菌菌株和培养该细菌的最佳做法的信息,这应为研究人员提供良好的资源。